263 related articles for article (PubMed ID: 11156851)
1. Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase.
West N; Guzik T; Black E; Channon K
Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):189-94. PubMed ID: 11156851
[TBL] [Abstract][Full Text] [Related]
2. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K
J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127
[TBL] [Abstract][Full Text] [Related]
3. Modulation of tissue factor protein expression in experimental venous bypass grafts.
Channon KM; Fulton GJ; Davies MG; Peters KG; Ezekowitz MD; Hagen PO; Annex BH
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1313-9. PubMed ID: 9261261
[TBL] [Abstract][Full Text] [Related]
4. c-Jun regulates shear- and injury-inducible Egr-1 expression, vein graft stenosis after autologous end-to-side transplantation in rabbits, and intimal hyperplasia in human saphenous veins.
Ni J; Waldman A; Khachigian LM
J Biol Chem; 2010 Feb; 285(6):4038-4048. PubMed ID: 19940138
[TBL] [Abstract][Full Text] [Related]
5. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
[TBL] [Abstract][Full Text] [Related]
6. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
[TBL] [Abstract][Full Text] [Related]
7. Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft.
Kodama A; Komori K; Hattori K; Yamanouchi D; Kajikuri J; Itoh T
J Vasc Surg; 2009 May; 49(5):1272-81. PubMed ID: 19233592
[TBL] [Abstract][Full Text] [Related]
8. Time course of the regression of intimal hyperplasia in experimental vein grafts.
Davies MG; Fulton GJ; Svendsen E; Hagen PO
Cardiovasc Pathol; 1999; 8(3):161-8. PubMed ID: 10722239
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923
[TBL] [Abstract][Full Text] [Related]
10. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
11. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
[TBL] [Abstract][Full Text] [Related]
12. [Local shRNA modulation of phosphatidylinositol 3-kinase signaling pathway reduces intimal hyperplasia in vein grafts: experiment with rats].
Deng YZ; Liu SJ; Ma L; Sun ZQ; Chen JJ; Su G; Liu C; Wang GH; Ke J
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1713-6. PubMed ID: 17825157
[TBL] [Abstract][Full Text] [Related]
13. Local treatment with recombinant tissue factor pathway inhibitor reduces the development of intimal hyperplasia in experimental vein grafts.
Huynh TT; Davies MG; Thompson MA; Ezekowitz MD; Hagen P; Annex BH
J Vasc Surg; 2001 Feb; 33(2):400-7. PubMed ID: 11174796
[TBL] [Abstract][Full Text] [Related]
14. Effect of external stenting and systemic hypertension on intimal hyperplasia in rat vein grafts.
Meguro T; Nakashima H; Kawada S; Tokunaga K; Ohmoto T
Neurosurgery; 2000 Apr; 46(4):963-9; discussion 969-70. PubMed ID: 10764272
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone prevents intimal hyperplasia in experimental rabbit vein grafts.
Morisaki K; Shibata R; Takahashi N; Ouchi N; Maehara Y; Murohara T; Komori K
J Vasc Surg; 2011 Dec; 54(6):1753-9. PubMed ID: 21890304
[TBL] [Abstract][Full Text] [Related]
16. The expression and function of G-proteins in experimental intimal hyperplasia.
Davies MG; Ramkumar V; Gettys TW; Hagen PO
J Clin Invest; 1994 Oct; 94(4):1680-9. PubMed ID: 7929847
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cell surface expression of endothelial adhesion molecules by ursolic acid prevents intimal hyperplasia of venous bypass grafts in rats.
Zeller I; Wiedemann D; Schwaiger S; Stelzmüller M; Kreutmayer S; Leberfing O; Stuppner H; Bernhard D
Eur J Cardiothorac Surg; 2012 Nov; 42(5):878-84. PubMed ID: 22551965
[TBL] [Abstract][Full Text] [Related]
18. All-trans-retinoic acid decreases cell proliferation and increases apoptosis in an animal model of vein bypass grafting.
Leville CD; Osipov VO; Jean-Claude JM; Seabrook GR; Towne JB; Cambria RA
Surgery; 2000 Aug; 128(2):178-84. PubMed ID: 10922989
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3.
Kallenbach K; Salcher R; Heim A; Karck M; Mignatti P; Haverich A
J Vasc Surg; 2009 Mar; 49(3):750-8. PubMed ID: 19268777
[TBL] [Abstract][Full Text] [Related]
20. Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts.
Huynh TT; Davies MG; Barber L; Svendsen E; Hagen PO
J Surg Res; 1998 Jul; 77(2):104-11. PubMed ID: 9733595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
